Metacam Oral Suspension For Dogs 10 ml
Metacam is a non-steroidal anti-inflammatory drug (NSAID) for use in dogsFor alleviation of inflammation and pain in chronic musculo-skeletal disorders. Read more
Metacam is a non-steroidal anti-inflammatory drug (NSAID) for use in dogs
For alleviation of inflammation and pain in chronic musculo-skeletal disorders.
Visit www.myvetmeds.co.uk / dog / anti-inflammatory-dog / metacam-oral-suspension-for-dogs-10-ml.htm
Product Description
About Metacam Oral Suspension For Dogs 10 ml
Metacam is a non-steroidal anti-inflammatory drug (NSAID) for use in dogs
For alleviation of inflammation and pain in chronic musculo-skeletal disorders.
Please note: images are for illustration purposes only and pack sizes/strengths and new packaging styles may not be reflected in the image shown.
Directions For Use
Directions for Use
|
Initial treatment is a single dose of 0.2 mg meloxicam/kg bodyweight on the first day. Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/ kg bodyweight.
For longer term treatment, once clinical response has been observed (after > 4 days), the dose of Metacam can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
Particular care should be taken with regard to the accuracy of dosing.
Shake well before use. To be administered orally either mixed with food or directly into the mouth. The suspension can be given using either the drop dispenser of the bottle (for very small breeds) or the Metacam measuring syringe provided in the package.
Dosing procedure using the drop dispenser of the bottle.
Initial dose : 4 drops/kg bodyweight.
Maintenance dose : 2 drops/kg bodyweight.
Dosing procedure using the measuring syringe.
The syringe fits onto the drop dispenser of the bottle and has a kg-bodyweight scale which corresponds to the maintenance dose (ie. 0.1 mg meloxicam/kg bodyweight). Thus for the first day of treatment, twice the maintenance volume will be required.
Alternatively, treatment may be initiated with Metacam 5 mg/ml solution for injection.
A clinical response is usually seen within 3-4 days. Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
Avoid the introduction of contamination during use
|
Active Ingredient
Metacam Oral Suspension For Dogs 10 ml ingredients
Each ml of Metacam Oral Suspension for Dogs contains 1.5 mg meloxicam as active ingredient (equivalent to 0.017 mg per drop) and 1.5 mg sodium benzoate (equivalent to 0.05 mg per drop).
Side Effects
Side effects of Metacam Oral Suspension For Dogs 10 ml
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastro-intestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. Do not use in case of hypersensitivy to the active substance or to any of the excipients.
Do not use in dogs less than 6 weeks of age.
Typical adverse drug reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood , apathy and renal failure have occasionally been reported. These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity. This product for dogs should not be used in cats as it is not suitable for use in this species. In cats, Metacam 0.5 mg/ml Oral Suspension for Cats should be used.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Metacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacological properties of the products used previously.
In case of overdose, symptomatic treatment should be initiated.
User precautions
Individuals sensitive to NSAIDs should avoid contact with the product. In case of accidental self-administration, seek medical advice immediately and show the package insert or label to the Doctor.
Any unused product or waste materials should be disposed or in accordance with national requirements for pharmaceutical products.
For animal treatment only.
Keep out of reach of children.
Additional Data
Metacam Oral Suspension For Dogs 10 ml specification
| Specification: | Detail: |
|---|---|
| Brands: | Boehringer Ingelheim |
| Product Form: | syrup |
| External Link: |
http://www.noahcompendium.co.uk/Boehringer_Ingelheim_Limited/documents/S5164.html |
| Strength/Size: | 10 ml |
